Navigation Links
Solera Holdings, Inc. Appoints Jason Brady as General Counsel

SAN DIEGO, March 11 /PRNewswire-FirstCall/ -- Solera Holdings, Inc. (NYSE: SLH), the leading global provider of software and services for the automobile insurance claims processing industry, today announced the appointment of Jason Brady as Senior Vice President and General Counsel, responsible for the Company's global legal organization, including corporate compliance and governance and mergers and acquisitions.

Brady has more than 12 years of relevant law experience, and in past positions has been responsible for SEC reporting and compliance, corporate transactions, corporate governance, litigation, commercial collaborations, intellectual property matters and employment matters.

He previously served as Vice President, General Counsel and Corporate Secretary at Xenogen Corporation, a publicly traded biotechnology company that was sold to Caliper Life Sciences, Inc. Prior to that, Brady held senior legal positions with Abbott Diabetes Care, TheraSense, Inc., Ensera, Inc. and AllAdvantage. At Ensera, he gained valuable insight into the software and services segment of the automobile insurance claims processing industry, working closely with Solera's founder, chairman and CEO, Tony Aquila, to build the business as a member of Ensera's senior management team. Jason started his career at the law firm of Wilson Sonsini Goodrich & Rosati in Palo Alto, California.

"I am looking forward to working with Jason Brady again as his legal counsel was instrumental at Ensera," said Aquila. "With Solera's May 2007 IPO and NYSE listing, and international business presence, the legal function remains critical to our success worldwide. Jason has a strong track record of achievement, and I intend to leverage his skills and expertise as part of our business and geographic expansion objectives."

Brady, 39, holds a Bachelor of Arts degree from the University of California at Los Angeles and a Juris Doctor degree from Santa Clara University School of Law. He is based in Solera's San Diego office and will report directly to Aquila.

About Solera

Solera is the leading global provider of software and services for the automobile insurance claims processing industry. Solera is active in over 50 countries across six continents. The Solera companies include Audatex in the United States, Canada, and in more than 45 additional countries, Informex in Belgium, Sidexa in France, ABZ in the Netherlands, Hollander serving the North American recycling market, and IMS providing medical review services. For more information, please refer to the Company's website at


Investor Relations:

Kamal Hamid

Solera Holdings, Inc.


Media Relations:

Kendra DeWitt

Solera Holdings, Inc.


SOURCE Solera Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Duane Reade Holdings, Inc. to Report Fourth Quarter and Full Year 2007 Financial Results
2. Whitemark Homes Signs Letter of Intent to Acquire Metiscan Holdings, Inc.
3. Vallon Holdings, LLC Launches New Subsidiary Focused on Contract Resources for the Minneapolis-St. Paul Life Science Industry
4. NightHawk Radiology Holdings, Inc. Announces Board Member Departure
5. NightHawk Radiology Holdings, Inc. to Speak at the Cowen and Company 28th Annual Health Care Conference on March 18, 2008
6. Lixte Biotechnology Holdings, Inc. Announces Further Developments Regarding the Anti-Cancer Activity of Its Patent-Pending Proprietary Compounds
7. Platinum Underwriters Holdings, Ltd. Reports Record Fourth Quarter and Year Ended December 31, 2007 Financial Results
8. NightHawk Radiology Holdings, Inc. Announces Fourth Quarter and Full-Year 2007 Results; Updates 2008 Guidance
9. Berkery Noyes Represented The Riverside Company on the Sale of HCPro Holdings, Inc. to Halyard Capital, LLC
10. NightHawk Radiology Holdings, Inc. Announces Time Change for Fourth Quarter and Full-Year 2007 Earnings Conference Call
11. MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc.
Post Your Comments:
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from reveals ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: